November 2025
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountChemist-4-u Market Share Analysis for November 2025
Wegovy (semaglutide) is an NHS-approved treatment for weight loss. When combined with healthy eating and exercise, it can help you lose up to 17% of your body weight.
Proven to be safe and effective for long-term weight loss
Stops cravings and helps keep you feeling fuller for longer
Available with fast, discreet home delivery in plain packaging
Prescribed and reviewed by licensed & regulated UK-based clinicians
The first weight loss medication proven to reduce heart disease risk by up to 20%
Chemist-4-u (including company regionals)
See more website traffic and engagement information- chemist-4-u.com
Chemist-4-u Revenue up to November 2025 is 15M - 25M
revenue generated by Chemist-4-u top domains
Chemist-4-u top domains revenue over 3 years
Revenue for Chemist-4-u top domains
Total visits to Chemist-4-u's top domains
Understand Chemist-4-u market share and potential market reach.
Total visits last 3 months
Subsidiaries Breakdown
Avg. visit duration in Chemist-4-u's top domains
Analyze Chemist-4-u engagement metrics.
Average visit duration last 3 months
Subsidiaries Breakdown
Avg. pageviews on Chemist-4-u's top domains
See how Chemist-4-u keep users engaged, nurture their interest, and encourage them to take the next step.
Average page views last 3 months
Subsidiaries Breakdown
